Lyka Labs Ltd.
| BSE: 500259 | Sector: Health care |
| NSE: LYKALABS | ISIN Code: INE933A01014 |
| BSE 00:00 | 17 Sep | 83.95 |
-2.90 (-3.34%) |
OPEN
85.00 |
HIGH
88.50 |
LOW
83.45 |
| NSE 00:00 | 17 Sep | 84.55 |
-2.20 (-2.54%) |
OPEN
87.50 |
HIGH
88.65 |
LOW
83.35 |
| OPEN | 85.00 |
| PREVIOUS CLOSE | 86.85 |
| VOLUME | 52238 |
| 52-Week high | 102.70 |
| 52-Week low | 16.10 |
| P/E | 19.43 |
| Mkt Cap.(Rs cr) | 241 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lyka Labs Ltd. (LYKALABS) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 770.25 | -1.36 | 804.40 | 452.60 | 184806.08 |
| Divi's Lab. | 5125.65 | -0.74 | 5269.00 | 2986.70 | 136060.38 |
| Dr Reddy's Labs | 4889.15 | -0.86 | 5613.65 | 4135.90 | 81345.68 |
| Cipla | 954.15 | 0.02 | 997.20 | 706.45 | 76966.51 |
| Apollo Hospitals | 4904.35 | 0.53 | 5122.00 | 1591.00 | 70514.74 |
| Gland Pharma | 3973.45 | -1.57 | 4350.00 | 1701.00 | 65244.05 |
| Piramal Enterp. | 2631.80 | -0.60 | 2856.80 | 1178.85 | 62807.91 |
| Cadila Health. | 557.95 | -1.12 | 673.70 | 358.10 | 57117.34 |
| Torrent Pharma. | 3096.45 | -0.49 | 3226.05 | 2311.30 | 52398.13 |
| Alkem Lab | 3833.55 | -0.91 | 3946.45 | 2544.25 | 45830.09 |
| Biocon | 377.45 | 0.15 | 487.70 | 327.75 | 45316.65 |
| Aurobindo Pharma | 745.80 | -1.15 | 1063.75 | 660.10 | 43696.42 |
| Abbott India | 20492.25 | -2.37 | 21850.00 | 13970.10 | 43546.03 |
| Lupin | 950.70 | -1.76 | 1267.50 | 856.00 | 43161.78 |
| Max Healthcare | 381.25 | -6.17 | 472.60 | 102.50 | 36826.84 |
| Laurus Labs | 651.20 | 0.21 | 723.55 | 247.55 | 34943.39 |
| Dr Lal Pathlabs | 3978.65 | -2.79 | 4243.00 | 1760.00 | 33158.07 |
| Ipca Labs. | 2496.15 | -2.87 | 2767.10 | 1786.05 | 31663.66 |
| Pfizer | 5873.60 | -2.45 | 6164.80 | 4200.00 | 26871.72 |
| Glaxosmi. Pharma | 1540.70 | -2.18 | 1805.00 | 1379.00 | 26101.00 |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
